Literature DB >> 16293555

Undiagnosed silent coeliac disease: a risk for underachievement?

Matti A Verkasalo1, Olli T Raitakari, Jorma Viikari, Jukka Marniemi, Erkki Savilahti.   

Abstract

OBJECTIVE: Silent coeliac disease is reported in 1% of Caucasian populations, but there is a lack of knowledge of its natural course and the risk of complications. The need for population screening is debated. We sought for complications of untreated coeliac disease in a well-defined cohort of Finnish adults.
MATERIAL AND METHODS: Subjects (n=2427, ages 24-39 years) attending the 21-year follow-up visit of the study "Cardiovascular Risk in Young Finns" completed an extensive questionnaire on their health, diet, social situation and family life, and were given a medical examination. Measurement of serum IgA-transglutaminase and IgA-endomysium antibodies identified 21 subjects with silent coeliac disease.
RESULTS: The subjects with silent coeliac disease did not differ from the rest of the cohort in age, gender, stature, weight, medical diagnoses (autoimmune, malignant), health concerns, use of alternative medications, physical activity, or in the cause of death their parents. They had lower serum HDL-cholesterol (1.12 versus 1.29 mmol/L; p=0.015), as described for active coeliac disease. Fewer (5.3% versus 22.8%; p=0.047) had a university or college degree or worked in managerial or professional positions (28% versus 45%; p=0.112).
CONCLUSIONS: The underachievement in education and working life observed in subjects with silent coeliac disease is a new and intriguing finding and may be related to the increased prevalence of depressive and disruptive behavioural disorders described in teenagers with untreated coeliac disease. Our findings add a new ingredient to the ongoing discussion regarding the need for population screening for silent coeliac disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293555     DOI: 10.1080/00365520510023792

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Seroprevalence of celiac disease among United Arab Emirates healthy adult nationals: a gender disparity.

Authors:  Yousif A Abu-Zeid; Waheeba S Jasem; Benjamin Lebwohl; Peter H Green; Gehad ElGhazali
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  Extraintestinal manifestations of celiac disease.

Authors:  Lincoln Hernandez; Peter H Green
Journal:  Curr Gastroenterol Rep       Date:  2006-10

3.  The changing frequency of celiac disease diagnosed at the Stollery Children's Hospital.

Authors:  Seema Rajani; Hien Q Huynh; Justine Turner
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

Review 4.  Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines.

Authors:  Jocelyn A Silvester; Mohsin Rashid
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

5.  Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study.

Authors:  Ilma R Korponay-Szabó; Katalin Szabados; Jánosné Pusztai; Katalin Uhrin; Eva Ludmány; Eva Nemes; Katri Kaukinen; Anikó Kapitány; Lotta Koskinen; Sándor Sipka; Anikó Imre; Markku Mäki
Journal:  BMJ       Date:  2007-12-06

6.  Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood.

Authors:  Laura Kivelä; Alina Popp; Taina Arvola; Heini Huhtala; Katri Kaukinen; Kalle Kurppa
Journal:  United European Gastroenterol J       Date:  2018-05-17       Impact factor: 4.623

7.  Mean platelet volume can indicate dietary adherence and disease severity of celiac disease.

Authors:  Emre Gerceker; Ahmed Ramiz Baykan; Serkan Cerrah; Hakan Yuceyar
Journal:  North Clin Istanb       Date:  2022-02-11

8.  Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use.

Authors:  Felicity L Bishop; G T Lewith
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-13       Impact factor: 2.629

9.  The characterization of the repertoire of wheat antigens and peptides involved in the humoral immune responses in patients with gluten sensitivity and Crohn's disease.

Authors:  Aristo Vojdani
Journal:  ISRN Allergy       Date:  2011-10-27

10.  A Quantitative Assessment of Gluten Cross-contact in the School Environment for Children With Celiac Disease.

Authors:  Vanessa M Weisbrod; Jocelyn A Silvester; Catherine Raber; William Suslovic; Shayna S Coburn; Blair Raber; Joyana McMahon; Amy Damast; Zachary Kramer; Benny Kerzner
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-03       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.